Drug Type Monoclonal antibody |
Synonyms |
Target- |
Mechanism T lymphocytes stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Imcheck Therapeutics SASStartup |
Active Organization Imcheck Therapeutics SASStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | FR | Imcheck Therapeutics SASStartup | - |
Solid tumor | Preclinical | FR | Imcheck Therapeutics SASStartup | - |